$IRBT
IROBOT CORP Stock $irbt

$irbt Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000115916717000019 Filed on May 05, 2017

Income Statement

Concept	2017 Q2	2016 Q2
Revenue	$168.5M	$130.8M
YoY Change	28.79%	-12.09%
Cost Of Revenue	$81.12M	$68.84M
YoY Change	17.84%	-12.59%
Gross Profit	$87.34M	$61.96M
YoY Change	40.96%	-11.53%
Gross Profit Margin	51.85%	47.37%
Selling, General & Admin	$40.20M	$36.70M
YoY Change	9.52%	-8.77%
% of Gross Profit	46.02%	59.24%
Research & Development	$25.51M	$19.73M
YoY Change	29.3%	5.32%
% of Gross Profit	29.2%	31.84%
Depreciation & Amortization	$3.486M	$3.375M
YoY Change	3.29%	-0.74%
% of Gross Profit	3.99%	5.45%
Operating Expenses	$65.71M	$56.43M
YoY Change	16.43%	-4.3%
Operating Profit	$21.64M	$5.529M
YoY Change	291.35%	-50.04%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$3.000K	$200.0K
YoY Change	-98.5%	-427.87%
Pretax Income	$21.64M	$5.729M
YoY Change	277.74%	-47.95%
Income Tax	$5.282M	$1.797M
% Of Pretax Income	24.41%	31.37%
Net Earnings	$16.36M	$3.932M
YoY Change	316.05%	-45.78%
Net Earnings / Revenue	9.71%	3.01%
Basic Earnings Per Share	$0.60	$0.14
Diluted Earnings Per Share	$0.58	$0.13
COMMON SHARES
Basic Shares Outstanding	27.30M shares	29.00M shares
Diluted Shares Outstanding	28.30M shares	29.47M shares

Balance Sheet

Concept	2017 Q2	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$275.7M	$246.7M
YoY Change	11.76%	10.23%
Cash & Equivalents	$235.7M	$216.0M
Short-Term Investments	$39.90M	$30.70M
Other Short-Term Assets	$7.317M	$11.77M
YoY Change	-37.83%	12.19%
Inventory	$57.13M	$52.76M
Prepaid Expenses
Receivables	$47.78M	$28.50M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$388.0M	$359.9M
YoY Change	7.82%	-2.23%
LONG-TERM ASSETS
Property, Plant & Equipment	$29.25M	$25.60M
YoY Change	14.26%	-14.17%
Goodwill	$290.0K	$48.80M
YoY Change	-99.41%	0.1%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$13.21M	$9.931M
YoY Change	33.06%	-15.6%
Total Long-Term Assets	$126.3M	$130.9M
YoY Change	-3.55%	12.82%
TOTAL ASSETS
Total Short-Term Assets	$388.0M	$359.9M
Total Long-Term Assets	$126.3M	$130.9M
Total Assets	$514.3M	$490.8M
YoY Change	4.78%	1.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$63.18M	$39.02M
YoY Change	61.93%	-15.49%
Accrued Expenses	$21.34M	$12.91M
YoY Change	65.32%	-17.26%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$100.1M	$70.39M
YoY Change	42.17%	-6.53%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$5.800M	$7.200M
YoY Change	-19.44%	111.76%
Total Long-Term Liabilities	$5.764M	$7.231M
YoY Change	-20.29%	114.57%
TOTAL LIABILITIES
Total Short-Term Liabilities	$100.1M	$70.39M
Total Long-Term Liabilities	$5.764M	$7.231M
Total Liabilities	$105.8M	$77.62M
YoY Change	36.35%	-1.34%
SHAREHOLDERS EQUITY
Retained Earnings	$243.4M	$188.9M
YoY Change	28.81%	23.58%
Common Stock	$165.2M	$224.2M
YoY Change	-26.32%	-11.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$408.4M	$413.2M
YoY Change
Total Liabilities & Shareholders Equity	$514.3M	$490.8M
YoY Change	4.78%	1.38%

Cashflow Statement

Concept	2017 Q2	2016 Q2
OPERATING ACTIVITIES
Net Income	$16.36M	$3.932M
YoY Change	316.05%	-45.78%
Depreciation, Depletion And Amortization	$3.486M	$3.375M
YoY Change	3.29%	-0.74%
Cash From Operating Activities	$26.76M	$48.62M
YoY Change	-44.97%	1085.93%
INVESTING ACTIVITIES
Capital Expenditures	$3.008M	$2.390M
YoY Change	25.86%	-317.27%
Acquisitions
YoY Change
Other Investing Activities	$504.0K	$523.0K
YoY Change	-3.63%	-187.17%
Cash From Investing Activities	-$3.510M	-$413.0K
YoY Change	749.88%	-75.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00	$12.02M
YoY Change	-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$2.056M	-$12.14M
YoY Change	-83.06%	-2122.5%
NET CHANGE
Cash From Operating Activities	$26.76M	$48.62M
Cash From Investing Activities	-$3.510M	-$413.0K
Cash From Financing Activities	-$2.056M	-$12.14M
Net Change In Cash	$21.19M	$36.08M
YoY Change	-41.25%	1102.5%
FREE CASH FLOW
Cash From Operating Activities	$26.76M	$48.62M
Capital Expenditures	$3.008M	$2.390M
Free Cash Flow	$23.75M	$46.23M
YoY Change	-48.63%	789.1%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q2	dei	Amendment Flag AmendmentFlag	false
CY2017Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-30
CY2017Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2017Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017Q2	dei	Document Period End Date DocumentPeriodEndDate	2017-04-01
CY2017Q2	dei	Document Type DocumentType	10-Q
CY2017Q2	dei	Entity Central Index Key EntityCentralIndexKey	0001159167
CY2017Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	27417081	shares
CY2017Q2	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2017Q2	dei	Entity Registrant Name EntityRegistrantName	IROBOT CORP
CY2017Q2	dei	Trading Symbol TradingSymbol	IRBT
CY2016Q4	irbt	Accrued Direct Fulfillment Costs AccruedDirectFulfillmentCosts	1722000	USD
CY2017Q2	irbt	Accrued Direct Fulfillment Costs AccruedDirectFulfillmentCosts	1191000	USD
CY2016Q4	irbt	Accrued Sales Tax AccruedSalesTax	422000	USD
CY2017Q2	irbt	Accrued Sales Tax AccruedSalesTax	196000	USD
CY2016Q4	irbt	Accruedcustomerdeposits Accruedcustomerdeposits	1171000	USD
CY2017Q2	irbt	Accruedcustomerdeposits Accruedcustomerdeposits	1273000	USD
CY2015Q2	irbt	Effective Date For Stock Options Plan EffectiveDateForStockOptionsPlan	2015-05-20
CY2016Q2	irbt	Warrantyaccrualadjustmentliabilityheldforsale Warrantyaccrualadjustmentliabilityheldforsale	-101000	USD
CY2017Q2	irbt	Warrantyaccrualadjustmentliabilityheldforsale Warrantyaccrualadjustmentliabilityheldforsale	0	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	67281000	USD
CY2017Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	63177000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	72909000	USD
CY2017Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	47780000	USD
CY2016Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1059000	USD
CY2017Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1413000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19854000	USD
CY2017Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	21343000	USD
CY2016Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	686000	USD
CY2017Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1087000	USD
CY2016Q4	us-gaap	Accrued Rent Current AccruedRentCurrent	327000	USD
CY2017Q2	us-gaap	Accrued Rent Current AccruedRentCurrent	597000	USD
CY2016Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	404000	USD
CY2017Q2	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	132000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-151000	USD
CY2017Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-168000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	161885000	USD
CY2017Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	164957000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	29000	USD
CY2017Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	30000	USD
CY2016Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	900000	USD
CY2017Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	900000	USD
CY2016Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	700000	shares
CY2017Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2016Q4	us-gaap	Assets Assets	507912000	USD
CY2017Q2	us-gaap	Assets Assets	514281000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	383670000	USD
CY2017Q2	us-gaap	Assets Current AssetsCurrent	388004000	USD
CY2016Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	39930000	USD
CY2017Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	39942000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	179915000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	215990000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	214523000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	235728000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	36075000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	21205000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27237870	shares
CY2017Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27409706	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27237870	shares
CY2017Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27409706	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	272000	USD
CY2017Q2	us-gaap	Common Stock Value CommonStockValue	274000	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4169000	USD
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	16342000	USD
CY2017Q2	us-gaap	Contractual Obligation ContractualObligation	127600000	USD
CY2016Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	68843000	USD
CY2017Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	81124000	USD
CY2016Q2	us-gaap	Costmethod Investments Other Than Temporary Impairment CostmethodInvestmentsOtherThanTemporaryImpairment	0	USD
CY2017Q2	us-gaap	Costmethod Investments Other Than Temporary Impairment CostmethodInvestmentsOtherThanTemporaryImpairment	155000	USD
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4486000	USD
CY2017Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4202000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	30585000	USD
CY2017Q2	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	31429000	USD
CY2016Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3375000	USD
CY2017Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3486000	USD
CY2017Q2	us-gaap	Disposal Group Including Discontinued Operation Other Income DisposalGroupIncludingDiscontinuedOperationOtherIncome	100000	USD
CY2016	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	400000	USD
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.60
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.58
CY2016Q2	us-gaap	Effect Of Exchange Rate On Cash EffectOfExchangeRateOnCash	0	USD
CY2017Q2	us-gaap	Effect Of Exchange Rate On Cash EffectOfExchangeRateOnCash	12000	USD
CY2016Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.314
CY2017Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.244
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	21015000	USD
CY2017Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	11348000	USD
CY2016Q2	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	267000	USD
CY2017Q2	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	0	USD
CY2016Q2	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	267000	USD
CY2017Q2	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	0	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	14793000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	15657000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	675000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	2593000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	900000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	900000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2818000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3457000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	27000000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	27000000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12207000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11343000	USD
CY2016Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	514281000	USD
CY2017Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-42000	USD
CY2016Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16764000	USD
CY2017Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17622000	USD
CY2016Q1	us-gaap	Goodwill Goodwill	48800000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	41041000	USD
CY2017Q2	us-gaap	Goodwill Goodwill	41041000	USD
CY2017Q2	us-gaap	Goodwill Gross GoodwillGross	41100000	USD
CY2016Q2	us-gaap	Gross Profit GrossProfit	61961000	USD
CY2017Q2	us-gaap	Gross Profit GrossProfit	87343000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	5729000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	21641000	USD
CY2016Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2017Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-11000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1797000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5282000	USD
CY2016Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid	4896000	USD
CY2017Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid	5563000	USD
CY2016Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-20626000	USD
CY2017Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-5026000	USD
CY2016Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-69879000	USD
CY2017Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-25128000	USD
CY2016Q2	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	47000	USD
CY2017Q2	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-17000	USD
CY2016Q2	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1144000	USD
CY2017Q2	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-284000	USD
CY2016Q2	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-4055000	USD
CY2017Q2	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-9670000	USD
CY2016Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3167000	USD
CY2017Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6546000	USD
CY2016Q2	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-2673000	USD
CY2017Q2	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	1016000	USD
CY2016Q2	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2985000	USD
CY2017Q2	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1745000	USD
CY2016Q2	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	3000	USD
CY2017Q2	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-558000	USD
CY2016Q2	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	-185000	USD
CY2017Q2	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	-27000	USD
CY2016Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	45861000	USD
CY2017Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	54287000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	50578000	USD
CY2017Q2	us-gaap	Inventory Net InventoryNet	57125000	USD
CY2016Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	4717000	USD
CY2017Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2838000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	507912000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	112636000	USD
CY2017Q2	us-gaap	Liabilities Current LiabilitiesCurrent	100070000	USD
CY2016Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	6320000	USD
CY2017Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	5764000	USD
CY2016Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-12135000	USD
CY2017Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2056000	USD
CY2016Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-413000	USD
CY2017Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3510000	USD
CY2016Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	48623000	USD
CY2017Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	26759000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	3932000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	16359000	USD
CY2016Q2	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	413000	USD
CY2017Q2	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	2461000	USD
CY2016Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	200000	USD
CY2017Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3000	USD
CY2017Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	56432000	USD
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	65705000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	5529000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	21638000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	18822000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	3960000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1382000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	2334000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	4417000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	4647000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	2082000	USD
CY2016Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1400000	USD
CY2017Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1600000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5599000	USD
CY2017Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6726000	USD
CY2016Q4	us-gaap	Other Assets Current OtherAssetsCurrent	5591000	USD
CY2017Q2	us-gaap	Other Assets Current OtherAssetsCurrent	7317000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	12877000	USD
CY2017Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13214000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	237000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	35000	USD
CY2016Q2	us-gaap	Other Noncash Expense OtherNoncashExpense	33000	USD
CY2017Q2	us-gaap	Other Noncash Expense OtherNoncashExpense	16000	USD
CY2016Q2	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	523000	USD
CY2017Q2	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	504000	USD
CY2016Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	12021000	USD
CY2017Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2016Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1218000	USD
CY2017Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2778000	USD
CY2016Q2	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	0	USD
CY2017Q2	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	3498000	USD
CY2016Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2390000	USD
CY2017Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3008000	USD
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	24500000	USD
CY2016Q2	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	2500000	USD
CY2017Q2	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	3500000	USD
CY2016Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	837000	USD
CY2017Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	722000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	27532000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	29250000	USD
CY2016Q2	us-gaap	Property Plant And Equipment Transfers And Changes PropertyPlantAndEquipmentTransfersAndChanges	5000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Transfers And Changes PropertyPlantAndEquipmentTransfersAndChanges	0	USD
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19728000	USD
CY2017Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	25508000	USD
CY2017Q2	us-gaap	Restructuring And Related Cost Incurred Cost RestructuringAndRelatedCostIncurredCost	27000	USD
CY2017Q2	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2016Q4	us-gaap	Restructuring Reserve RestructuringReserve	188000	USD
CY2017Q2	us-gaap	Restructuring Reserve RestructuringReserve	161000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	226950000	USD
CY2017Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	243384000	USD
CY2016Q2	us-gaap	Sales Revenue Net SalesRevenueNet	130804000	USD
CY2017Q2	us-gaap	Sales Revenue Net SalesRevenueNet	168467000	USD
CY2016Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	19940000	USD
CY2017Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	22575000	USD
CY2016Q2	us-gaap	Share Based Compensation ShareBasedCompensation	3892000	USD
CY2017Q2	us-gaap	Share Based Compensation ShareBasedCompensation	4331000	USD
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	10975	shares
CY2017Q1	us-gaap	Share Price SharePrice	57.33
CY2016Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	6907000	USD
CY2016Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	6253000	USD
CY2016Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	8464000	USD
CY2017Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	8728000	USD
CY2016Q4	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	8464000	USD
CY2017Q2	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	8728000	USD
CY2016Q2	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	1430000	USD
CY2017Q2	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	1730000	USD
CY2016Q2	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	877000	USD
CY2017Q2	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	1994000	USD
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29474000	shares
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	388956000	USD
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	408447000	USD
CY2016Q2	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	0	USD
CY2017Q2	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-52000	USD
CY2016Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	139000	USD
CY2017Q2	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	112000	USD
CY2016Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	470000	shares
CY2017Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	991000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28295000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29004000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27304000	shares
CY2017Q2	us-gaap	Fiscal Period FiscalPeriod	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fiscal Year-End</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company operates and reports using a </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">52</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">-53</font><font style="font-family:inherit;font-size:10pt;"> week fiscal year ending on the Saturday closest to December 31. Accordingly, the Company’s fiscal quarters end on the Saturday that falls closest to the last day of the third month of each quarter.</font></div></div>
CY2017Q2	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Description of Business</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">iRobot Corporation ("iRobot" or the "Company") designs and builds robots that empower people to do more. The Company develops robotic technology and applies it to produce and market consumer robots. The Company’s revenue is primarily generated from product sales.</font></div></div>
CY2017Q2	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of these financial statements in conformity with accounting principles generally accepted in the United States requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and disclosure of contingent assets and liabilities. On an ongoing basis, management evaluates these estimates and judgments, including those related to revenue recognition, sales returns, price protection, bad debts, warranty claims, inventory reserves, valuation of investments, valuation of goodwill and intangible assets, assumptions used in valuing stock-based compensation instruments and income taxes. The Company bases these estimates on historical and anticipated results and trends, and on various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. These estimates form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. By their nature, estimates are subject to an inherent degree of uncertainty. Actual results may differ from the Company’s estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001159167-17-000019-index-headers.html	Edgar Link	pending
0001159167-17-000019-index.html	Edgar Link	pending
0001159167-17-000019.txt	Edgar Link	pending
0001159167-17-000019-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
irbt-20170401.xml	Edgar Link	completed
irbt-20170401.xsd	Edgar Link	pending
irbt-20170401_cal.xml	Edgar Link	unprocessable
irbt-20170401_def.xml	Edgar Link	unprocessable
irbt-20170401_lab.xml	Edgar Link	unprocessable
irbt-20170401_pre.xml	Edgar Link	unprocessable
irbt-201741x10q.htm	Edgar Link	pending
irbtexhibit1014117.htm	Edgar Link	pending
irbtexhibit1024117.htm	Edgar Link	pending
irbtexhibit3114117.htm	Edgar Link	pending
irbtexhibit3124117.htm	Edgar Link	pending
irbtexhibit3214117.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IRBT
IROBOT CORP Stock $irbt

2017 Q2 Form 10-Q Financial Statement

#000115916717000019 Filed on May 05, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IRBT IROBOT CORP Stock $irbt

2017 Q2 Form 10-Q Financial Statement

#000115916717000019 Filed on May 05, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IRBT
IROBOT CORP Stock $irbt